{"id":"W4407377433","doi":"10.1080/1750743x.2025.2457931","title":"Benralizumab in severe eosinophilic asthma by biologic use and key clinical subgroups: real-world XALOC-1 programme: a plain language summary of publication","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"McGill University; McMaster University; AstraZeneca","keywords":"Benralizumab; Asthma; Medicine; Eosinophilic; Internal medicine; Pathology; Eosinophil; Mepolizumab","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003334391,0.000173024,0.0004274616,0.0002559535,0.00004424058,0.00003876608,0.0001191281,0.0001662963,0.00004571103],"category_scores_gemma":[0.0001725568,0.0001337009,0.0001143319,0.000512635,0.0002329905,0.0001407354,0.00003545623,0.0002098325,0.000003410624],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006183206,"about_ca_system_score_gemma":0.0001591714,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007340434,"about_ca_topic_score_gemma":0.0002678491,"domain_scores_codex":[0.9984887,0.0002170151,0.0005871271,0.0003244448,0.0001324795,0.0002502557],"domain_scores_gemma":[0.9990382,0.0002253007,0.0001567366,0.0004058509,0.00009358225,0.00008035011],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001580112,0.001038115,0.7187656,0.0001159919,0.0001129851,0.000024191,0.0003372707,3.286478e-7,0.01300373,0.000828394,0.004883754,0.2593096],"study_design_scores_gemma":[0.005080309,0.0007390906,0.9065824,0.0002813306,0.00002277644,0.000006994083,0.0003159143,0.00005158655,0.0007139021,0.00007225842,0.08596072,0.0001727516],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875987,0.009904671,0.00001927684,0.001090087,0.00006543667,0.0006740577,0.00005537197,0.00007233636,0.0005200466],"genre_scores_gemma":[0.9929935,0.002681574,0.0002578707,0.001609833,0.00004404721,0.00006692055,0.0002495166,0.00002122109,0.002075501],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2591368,"threshold_uncertainty_score":0.5452166,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0220841725104322,"score_gpt":0.3304853682888036,"score_spread":0.3084011957783714,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}